MoneyWorks4Me

The sales for the March 2025 quarter moved down -34.26% to Rs. 178.22 millions as compared to Rs. 271.08 millions during the year ago period.The Company's Net profit for the March 2025 quarter have declined marginally to Rs. 24.88  millions as against Rs. 29.64 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 36.33 millions from 42.43 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 178.22 271.08 -34.26 665.08 858.31 -22.51 665.08 858.31 -22.51
Other Income 5.75 4.32 33.10 18.39 15.81 16.32 18.39 15.81 16.32
PBIDT 36.33 42.43 -14.38 134.46 140.09 -4.02 134.46 140.09 -4.02
Interest 0.06 1.02 -94.12 0.73 1.81 -59.67 0.73 1.81 -59.67
PBDT 36.27 41.41 -12.41 133.73 138.28 -3.29 133.73 138.28 -3.29
Depreciation 2.27 1.76 28.98 9.05 5.75 57.39 9.05 5.75 57.39
PBT 34.00 39.65 -14.25 124.68 132.53 -5.92 124.68 132.53 -5.92
TAX 9.12 10.01 -8.89 31.94 33.84 -5.61 31.94 33.84 -5.61
Deferred Tax 3.33 3.93 -15.27 6.50 4.39 48.06 6.50 4.39 48.06
PAT 24.88 29.64 -16.06 92.74 98.69 -6.03 92.74 98.69 -6.03
Equity 57.57 57.57 0.00 57.57 57.57 0.00 57.57 57.57 0.00
PBIDTM(%) 20.38 15.65 30.24 20.22 16.32 23.87 20.22 16.32 23.87
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..